Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirena vs Systemic Progestin for Endometrial Hyperplasia
NCT01074892Phase 4Completed
- Sponsor
- University Hospital of North Norway
- Start
- May 2005
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of avatrombopag in endometrial hyperplasia (EH) (3 arms), sponsored by University Hospital of North Norway. Primary endpoint: Regression of hyperplasia related to treatment arm at 6 months. Started May 2005; status: completed.
02
Drugs
avatrombopag
03
Conditions
endometrial hyperplasia (EH)
Beyond the preview
Go deeper on NCT01074892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01074892.